Analysen von Jo Walton
| 14.05.24 | Bayer Neutral | UBS AG | |
| 10.05.24 | Sanofi Buy | UBS AG | |
| 02.05.24 | Novo Nordisk Neutral | UBS AG | |
| 02.05.24 | GSK Buy | UBS AG | |
| 01.05.24 | GSK Buy | UBS AG | |
| 29.04.24 | GSK Buy | UBS AG | |
| 29.04.24 | Novo Nordisk Neutral | UBS AG | |
| 22.04.24 | Sanofi Buy | UBS AG | |
|
Werbung
|
|||
| 12.04.24 | Bayer Neutral | UBS AG | |
| 26.03.24 | Novo Nordisk Neutral | UBS AG | |
| 19.03.24 | GSK Buy | UBS AG | |
| 11.03.24 | Novo Nordisk Neutral | UBS AG | |
| 07.03.24 | GSK Buy | UBS AG | |
| 05.03.24 | Novo Nordisk Neutral | UBS AG | |
| 05.03.24 | Bayer Neutral | UBS AG | |
| 27.02.24 | Novo Nordisk Neutral | UBS AG | |
| 20.02.24 | Bayer Neutral | UBS AG | |
| 09.02.24 | GSK Buy | UBS AG | |
| 06.02.24 | GSK Buy | UBS AG | |
| 05.02.24 | Novo Nordisk Neutral | UBS AG | |
| 05.02.24 | Sanofi Buy | UBS AG | |
| 02.02.24 | Novo Nordisk Neutral | UBS AG | |
| 01.02.24 | Sanofi Buy | UBS AG | |
| 31.01.24 | Novo Nordisk Neutral | UBS AG | |
| 31.01.24 | GSK Buy | UBS AG | |
| 31.01.24 | Sanofi Buy | UBS AG | |
| 30.01.24 | GSK Buy | UBS AG | |
| 30.01.24 | Novo Nordisk Neutral | UBS AG | |
| 29.01.24 | Bayer Neutral | UBS AG | |
| 23.01.24 | Sanofi Buy | UBS AG | |
| 18.01.24 | Bayer Neutral | UBS AG | |
| 15.01.24 | GSK Buy | UBS AG | |
| 15.01.24 | Sanofi Buy | UBS AG | |
| 15.01.24 | Novo Nordisk Neutral | UBS AG | |
| 08.01.24 | Bayer Neutral | UBS AG | |
| 19.12.23 | Bayer Neutral | UBS AG | |
| 04.12.23 | Bayer Neutral | UBS AG | |
| 31.10.22 | Sanofi Outperform | Credit Suisse Group | |
| 31.10.22 | Bayer Neutral | Credit Suisse Group | |
| 12.10.22 | GSK Neutral | Credit Suisse Group | |
| 11.05.22 | Bayer Neutral | Credit Suisse Group | |
| 17.01.22 | GSK Underperform | Credit Suisse Group | |
| 10.11.21 | Bayer Neutral | Credit Suisse Group | |
| 28.10.21 | GSK Underperform | Credit Suisse Group | |
| 06.08.21 | Bayer Neutral | Credit Suisse Group | |
| 22.07.21 | Novartis Neutral | Credit Suisse Group | |
| 07.10.20 | Sanofi Outperform | Credit Suisse Group | |
| 17.04.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 04.07.19 | Bayer Outperform | Credit Suisse Group | |
| 02.05.19 | GSK Neutral | Credit Suisse Group | |